Avantax Advisory Services, Inc. Elevance Health, Inc. Transaction History

Avantax Advisory Services, Inc.

$15.6 Billion
Q4 2024

A detailed history of Avantax Advisory Services, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 15,726 shares of ELV stock, worth $6.01 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,726

Previous 17,898 12.14%

Holding current value

$6.01 Million

Previous $9.31 Million 37.58%

% of portfolio

0.04%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$365.96 - $514.62 $794,865 - $1.12 Million	-2,172 Reduced 12.14%	15,726 $5.81 Million
Q3 2024 Nov 13, 2024	BUY	$500.12 - $562.29 $788,189 - $886,169	1,576 Added 9.66%	17,898 $9.31 Million
Q2 2024 Aug 09, 2024	BUY	$497.49 - $547.8 $5.3 Million - $5.84 Million	10,659 Added 188.22%	16,322 $8.84 Million
Q1 2024 May 08, 2024	BUY	$464.61 - $519.96 $46,925 - $52,515	101 Added 1.82%	5,663 $2.94 Million
Q4 2023 Feb 07, 2024	BUY	$433.51 - $488.06 $321,664 - $362,140	742 Added 15.39%	5,562 $2.62 Million
Q3 2023 Nov 07, 2023	SELL	$414.13 - $475.93 $292,789 - $336,482	-707 Reduced 12.79%	4,820 $2.1 Million
Q2 2023 Aug 11, 2023	BUY	$436.33 - $496.2 $36,215 - $41,184	83 Added 1.52%	5,527 $2.46 Million
Q1 2023 Apr 28, 2023	BUY	$446.3 - $502.2 $83,458 - $93,911	187 Added 3.56%	5,444 $2.5 Million
Q4 2022 Feb 13, 2023	SELL	$465.23 - $546.77 $930 - $1,093	-2 Reduced 0.04%	5,257 $2.7 Million
Q3 2022 Nov 01, 2022	SELL	$445.98 - $507.0 $44,152 - $50,193	-99 Reduced 1.85%	5,259 $2.39 Million
Q2 2022 Aug 02, 2022	BUY	$444.32 - $529.84 $262,593 - $313,135	591 Added 12.4%	5,358 $2.59 Million
Q1 2022 Apr 27, 2022	BUY	$428.44 - $502.48 $110,965 - $130,142	259 Added 5.75%	4,767 $2.32 Million
Q4 2021 Jan 24, 2022	BUY	$370.08 - $467.67 $118,055 - $149,186	319 Added 7.62%	4,508 $2.09 Million
Q3 2021 Oct 21, 2021	BUY	$357.51 - $398.13 $876,257 - $975,816	2,451 Added 141.02%	4,189 $1.56 Million
Q2 2021 Jul 29, 2021	BUY	$352.19 - $401.9 $78,538 - $89,623	223 Added 14.72%	1,738 $665,000
Q1 2021 May 13, 2021	SELL	$287.7 - $371.31 $333,156 - $429,976	-1,158 Reduced 43.32%	1,515 $544,000
Q4 2020 Jan 22, 2021	SELL	$270.17 - $333.15 $745,939 - $919,827	-2,761 Reduced 50.81%	2,673 $856,000
Q3 2020 Oct 14, 2020	BUY	$245.73 - $284.63 $1.05 Million - $1.22 Million	4,269 Added 366.44%	5,434 $1.46 Million
Q2 2020 Aug 06, 2020	SELL	$203.3 - $300.59 $18,500 - $27,353	-91 Reduced 7.25%	1,165 $309,000
Q1 2020 Apr 30, 2020	BUY	$174.68 - $307.74 $66,203 - $116,633	379 Added 43.22%	1,256 $283,000
Q4 2019 Feb 14, 2020	BUY	$234.82 - $306.42 $205,937 - $268,730	877 New	877 $268,000

Others Institutions Holding ELV

# of Institutions

1,793

Shares Held

206M

Call Options Held

1.52M

Put Options Held

1.37M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $91.8B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Elevance Health, Inc. Transaction History